Literature DB >> 22167245

Deferasirox in mucormycosis: hopefully, not defeated.

Rajeev Soman, Neha Gupta, Anjali Shetty, Camilla Rodrigues.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22167245     DOI： 10.1093/jac/dkr529

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

Review 1.  Update on mucormycosis pathogenesis.

Authors:  Ashraf S Ibrahim; Dimitrios P Kontoyiannis
Journal:  Curr Opin Infect Dis       Date:  2013-12       Impact factor: 4.915

Review 2.  Human Fungal Pathogens of Mucorales and Entomophthorales.

Authors:  Leonel Mendoza; Raquel Vilela; Kerstin Voelz; Ashraf S Ibrahim; Kerstin Voigt; Soo Chan Lee
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

Review 3.  Host-iron assimilation: pathogenesis and novel therapies of mucormycosis.

Authors:  Ashraf S Ibrahim
Journal:  Mycoses       Date:  2014-09-01       Impact factor: 4.377

4.  Deferiprone as adjunctive treatment for patients with invasive mucormycosis: A retrospective case series.

Authors:  Maria N Chitasombat; Pimjai Niparuck
Journal:  Infect Dis Rep       Date:  2018-09-25

5.  Lethargy and vision loss: successful management of rhinocerebral mucormycosis.

Authors:  Ramzi Mulki; Muhammad Masab; Glenn Eiger; Sarah Perloff
Journal:  BMJ Case Rep       Date:  2016-06-02

Review 6.  Immunomodulation as Therapy for Fungal Infection: Are We Closer?

Authors:  Qi Hui Sam; Wen Shan Yew; Chaminda J Seneviratne; Matthew Wook Chang; Louis Yi Ann Chai
Journal:  Front Microbiol       Date:  2018-07-25       Impact factor: 5.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.